Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 812027, 5 pages
http://dx.doi.org/10.1155/2015/812027
Research Article

Collagen Type XI Alpha 1 Expression in Intraductal Papillomas Predicts Malignant Recurrence

1Anatomía Patológica, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain
2IDIVAL, 39011 Santander, Spain
3Ginecología y Obstetricia, Hospital Universitario de Puerto Real, 11510 Puerto Real, Spain
4Oncología Médica, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain
5Radiodiagnóstico, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain
6Anatomía Patológica, Hospital Universitario de Puerto Real, 11510 Puerto Real, Spain
7Anatomía Patológica, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain
8Gerencia Atención Primaria, Servicio Cántabro de Salud, 39011 Santander, Spain

Received 14 January 2015; Accepted 17 February 2015

Academic Editor: Konstantinos Arnaoutakis

Copyright © 2015 Javier Freire et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal, “Breast cancer statistics, 2011,” CA: A Cancer Journal for Clinicians, vol. 61, no. 6, pp. 409–418, 2011. View at Google Scholar
  3. M. T. Tirona, “Breast cancer screening update,” American Family Physician, vol. 87, no. 4, pp. 274–278, 2013. View at Google Scholar · View at Scopus
  4. L. C. Collins and S. J. Schnitt, “Papillary lesions of the breast: selected diagnostic and management issues,” Histopathology, vol. 52, no. 1, pp. 20–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-H. Ueng, T. Mezzetti, and F. A. Tavassoli, “Papillary neoplasms of the breast: a review,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 6, pp. 893–907, 2009. View at Google Scholar · View at Scopus
  6. A. M. Mulligan and F. P. O'Malley, “Papillary lesions of the breast: a review,” Advances in Anatomic Pathology, vol. 14, no. 2, pp. 108–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Moumen, A. Chiche, S. Cagnet et al., “The mammary myoepithelial cell,” International Journal of Developmental Biology, vol. 55, no. 7–9, pp. 763–771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Shouhed, F. F. Amersi, R. Spurrier et al., “Intraductal papillary lesions of the breast: clinical and pathological correlation,” The American Surgeon, vol. 78, no. 10, pp. 1161–1165, 2012. View at Google Scholar · View at Scopus
  9. P. P. Rosen, “Papilloma and related benign tumors,” in Rosen's Breast Pathology, P. P. Rosen, Ed., pp. 85–136, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009. View at Google Scholar
  10. E. K. Valdes, P. I. Tartter, E. Genelus-Dominique, D.-A. Guilbaud, S. Rosenbaum-Smith, and A. Estabrook, “Significance of papillary lesions at percutaneous breast biopsy,” Annals of Surgical Oncology, vol. 13, no. 4, pp. 480–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Rizzo, M. J. Lund, G. Oprea, M. Schniederjan, W. C. Wood, and M. Mosunjac, “Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy,” Annals of Surgical Oncology, vol. 15, no. 4, pp. 1040–1047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Skandarajah, L. Field, A. Yuen Larn Mou et al., “Benign papilloma on core biopsy requires surgical excision,” Annals of Surgical Oncology, vol. 15, no. 8, pp. 2272–2277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. N. Agoff and T. J. Lawton, “Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy,” The American Journal of Clinical Pathology, vol. 122, no. 3, pp. 440–443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. E. L. Rosen, R. C. Bentley, J. A. Baker, and M. S. Soo, “Imaging-guided core needle biopsy of papillary lesions of the breast,” American Journal of Roentgenology, vol. 179, no. 5, pp. 1185–1192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Sohn, J. Keylock, Z. Arthurs et al., “Breast papillomas in the era of percutaneous needle biopsy,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2979–2984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. D. Choi, G. Y. Gong, M. J. Kim et al., “Clinical and cytologic features of papillary neoplasms of the breast,” Acta Cytologica, vol. 50, no. 1, pp. 35–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Gomez-Aracil, E. Mayayo, J. Azua, and A. Arraiza, “Papillary neoplasms of the breast: clues in fine needle aspiration cytology,” Cytopathology, vol. 13, no. 1, pp. 22–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Erkan, N. Weis, Z. Pan et al., “Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells,” Molecular Cancer, vol. 9, article 88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I.-W. Chong, M.-Y. Chang, H.-C. Chang et al., “Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer,” Oncology Reports, vol. 16, no. 5, pp. 981–988, 2006. View at Google Scholar · View at Scopus
  20. Y. Zhao, T. Zhou, A. Li et al., “A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach,” Anatomical Record (Hoboken), vol. 292, no. 5, pp. 692–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. B. Bowen, A. P. Reimers, S. Luman, J. D. Kronz, W. E. Fyffe, and J. Thom, “Immunohistochemical localization of collagen type XI α1 and α2 chains in human colon tissue,” Journal of Histochemistry & Cytochemistry, vol. 56, no. 3, pp. 275–283, 2008. View at Google Scholar
  22. H. Fischer, S. Salahshor, R. Stenling et al., “COL11A1 in FAP polyps and in sporadic colorectal tumors,” BMC Cancer, vol. 1, article 17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Fischer, R. Stenling, C. Rubio, and A. Lindblom, “Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2,” Carcinogenesis, vol. 22, no. 6, pp. 875–878, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Freire, “Collagen, type XI, alpha 1: an accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies,” Pathology—Research and Practice, vol. 210, no. 12, pp. 879–884, 2014. View at Publisher · View at Google Scholar
  25. M. García-Ocaña, F. Vázquez, C. García-Pravia et al., “Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component,” International Journal of Oncology, vol. 40, no. 5, pp. 1447–1454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Ibarra, “Papillary lesions of the breast,” Breast Journal, vol. 12, no. 3, pp. 237–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. L. E. Bennett, S. V. Ghate, R. Bentley, and J. A. Baker, “Is surgical excision of core biopsy proven benign papillomas of the breast necessary?” Academic Radiology, vol. 17, no. 5, pp. 553–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. W.-H. Kil, E. Y. Cho, J. H. Kim, S.-J. Nam, and J.-H. Yang, “Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy?” Breast, vol. 17, no. 3, pp. 258–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Lu, E. Y. Tan, B. Ho, J. J. C. Chen, and P. M. Y. Chan, “Surgical excision of intraductal breast papilloma diagnosed on core biopsy,” ANZ Journal of Surgery, vol. 82, no. 3, pp. 168–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. T. C. Putti, S. E. Pinder, C. W. Elston, A. H. S. Lee, and I. O. Ellis, “Breast pathology practice: most common problems in a consultation service,” Histopathology, vol. 47, no. 5, pp. 445–457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Irfan and R. F. Brem, “Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy,” Breast Journal, vol. 8, no. 4, pp. 230–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. W. Jacobs, J. L. Connolly, and S. J. Schnitt, “Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?” The American Journal of Surgical Pathology, vol. 26, no. 9, pp. 1095–1110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Puglisi, C. Zuiani, M. Bazzocchi et al., “Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions,” Oncology, vol. 65, no. 4, pp. 311–315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Ahmadiyeh, M. A. Stoleru, S. Raza, S. C. Lester, and M. Golshan, “Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome,” Annals of Surgical Oncology, vol. 16, no. 8, pp. 2264–2269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. Carder, J. Garvican, I. Haigh, and J. C. Liston, “Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast,” Histopathology, vol. 46, no. 3, pp. 320–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Wen and W. Cheng, “Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors,” Annals of Surgical Oncology, vol. 20, no. 1, pp. 94–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. G. M. K. Tse, P.-H. Tan, T. K. F. Ma, C. B. Gilks, C. S. P. Poon, and B. K. B. Law, “CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast,” Journal of Clinical Pathology, vol. 58, no. 11, pp. 1185–1188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Saddik, R. Lai, L. J. Medeiros, A. McCourty, and R. K. Brynes, “Differential expression of cyclin D1 in breast papillary carcinomas and benign papillomas: an immunohistochemical study,” Archives of Pathology and Laboratory Medicine, vol. 123, no. 2, pp. 152–156, 1999. View at Google Scholar · View at Scopus
  39. M. Yoshida, H. Tsuda, S. Yamamoto et al., “Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions,” Virchows Archiv, vol. 460, no. 5, pp. 497–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Wynveen, T. Nehhozina, M. Akram et al., “Intracystic papillary carcinoma of the breast: an in situ or invasive tumor? results of immunohistochemical analysis and clinical follow-up,” American Journal of Surgical Pathology, vol. 35, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. E. A. Rakha, N. Gandhi, F. Climent et al., “Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis,” The American Journal of Surgical Pathology, vol. 35, no. 8, pp. 1093–1103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Li, O. Weaver, M. M. Desouki et al., “Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy,” The American Journal of Clinical Pathology, vol. 138, no. 6, pp. 789–795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. F. O'Malley, D. Visscher, G. MacGrogan, P. H. Tan, and S. Ichihara, “Intraductal papilloma,” in WHO Classification of Tumours of the Breast, S. R. Lakhani, I. O. Ellis, S. J. Schnitt, P. H. Tan, and M. J. van de Vijver, Eds., pp. 99–105, International Agency of Research on Cancer (IARC), Lyon, France, 2012. View at Google Scholar
  44. J. Cuzick, T. Powles, U. Veronesi et al., “Overview of the main outcomes in breast-cancer prevention trials,” The Lancet, vol. 361, no. 9354, pp. 296–300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Fisher, J. P. Costantino, D. L. Wickerham et al., “Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study,” Journal of the National Cancer Institute, vol. 97, no. 22, pp. 1652–1662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. V. G. Vogel, J. P. Costantino, D. L. Wickerham et al., “Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial,” The Journal of the American Medical Association, vol. 295, no. 23, pp. 2727–2741, 2006. View at Publisher · View at Google Scholar
  47. P. E. Goss, J. N. Ingle, J. Ales-Martinez et al., “Exemestane for breast-cancer prevention in postmenopausal women,” The New England Journal of Medicine, vol. 364, no. 25, pp. 2381–2391, 2011. View at Publisher · View at Google Scholar